Jennison Associates LLC Intercept Pharmaceuticals, Inc. Transaction History

Jennison Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 06, 2020	SELL	$48.35 - $118.68 $8.16 Million - $20 Million	-168,706 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$57.36 - $124.1 $59,597 - $128,939	1,039 Added 0.62%	168,706 $20.9 Million
Q3 2019 Nov 08, 2019	SELL	$58.69 - $80.46 $826,413 - $1.13 Million	-14,081 Reduced 7.75%	167,667 $11.1 Million
Q2 2019 Aug 06, 2019	SELL	$77.77 - $120.68 $310,380 - $481,633	-3,991 Reduced 2.15%	181,748 $0
Q1 2019 May 10, 2019	BUY	$91.83 - $120.68 $17.1 Million - $22.4 Million	185,739 New	185,739 $20.8 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.